TP53 and cancer: Germline mutations in genes encoding proteins that regulate DNA repair and the response to double-strand DNA breaks have been recognized as pathogenic factors contributing to hereditary cancer predisposition.The ATM-CHEK2-TP53 gene group has been shown to initiate the primary DNA damage response and acts as a barrier to cancer development.